- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about VALN
Recent news which mentions VALN
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 20, 2022
From Benzinga
From InvestorPlace
Why O2Micro International Is Trading Higher By 7%; Here Are 25 Stocks Moving Premarket
September 20, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
September 19, 2022
From Benzinga
Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session
September 19, 2022
From Benzinga
Valneva Cuts Ties With Its COVID-19 Vaccine Manufacturing Partner In Germany
September 19, 2022
Tickers
VALN
From Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
September 19, 2022
From InvestorPlace
Valneva, Take-Two Interactive And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
September 19, 2022
From Benzinga
Why bluebird bio Is Trading Higher By Around 19%; Here Are 31 Stocks Moving Premarket
September 19, 2022
From Benzinga
From Benzinga
What will insurance coverage of COVID-19 vaccines and treatments look like? The Biden administration is trying to figure that out
August 19, 2022
From MarketWatch
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
August 18, 2022
From Benzinga
From Benzinga
Valneva Cuts FY22 COVID-19 Vaccine Sales Outlook, Needs Funding To Invest In Next-Gen COVID-19 Shot
August 11, 2022
Tickers
VALN
From Benzinga
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
From Benzinga
Recap of Monday's Biotech Catalysts - End Of the Day Summary
August 08, 2022
From Benzinga
Pfizer And Valneva Commence Late-Stage Lyme Disease Study
August 08, 2022
From Benzinga
Lyme Disease And Climate Change Reinvigorates Valneva's Vaccine Efforts After COVID Shot Disappointment
August 08, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2022
August 03, 2022
From Benzinga
Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study
August 02, 2022
From Benzinga
From Benzinga
How Pfizer Plans to Unlock Another Mass-Market Vaccine
June 27, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Why Dynavax Crushed the Market on Thursday
June 23, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.